Ani Pharmaceuticals (ANIP) Inventory (2012 - 2026)

Ani Pharmaceuticals (ANIP) has 15 years of Inventory data on file, last reported at $143.5 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 4.41% year-over-year to $143.5 million; the trailing twelve-month figure through Mar 2026 stood at $143.5 million (up 4.41% YoY), and the FY2025 full-year result was $143.1 million, up 4.59% from the prior year.
• Inventory held at $143.5 million in Q1 2026, from $143.1 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $148.0 million in Q3 2024 to a low of $83.2 million in Q1 2022.
• A 5-year average of $120.8 million and a median of $113.8 million in 2024 frame the typical range for Inventory.
• Across the five-year window, Inventory jumped 57.44% in 2022 and dropped 1.06% in 2025, its largest moves.
• Tracing ANIP's Inventory over 5 years: stood at $105.4 million in 2022, then rose by 5.54% to $111.2 million in 2023, then gained by 23.01% to $136.8 million in 2024, then advanced by 4.59% to $143.1 million in 2025, then advanced by 0.28% to $143.5 million in 2026.
• Business Quant data shows ANIP's Inventory at $143.5 million in Q1 2026, $143.1 million in Q4 2025, and $146.5 million in Q3 2025.